Amundi Asset Management US’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-30,700
Closed -$616K 1547
2020
Q4
$616K Sell
30,700
-1,151
-4% -$24.1K ﹤0.01% 1263
2020
Q3
$779K Hold
31,851
﹤0.01% 1203
2020
Q2
$756K Sell
31,851
-189
-0.6% -$4.38K ﹤0.01% 1211
2020
Q1
$552K Sell
32,040
-16,941
-35% -$310K ﹤0.01% 1188
2019
Q4
$863K Hold
48,981
﹤0.01% 1264
2019
Q3
$867K Sell
48,981
-8,579
-15% -$174K ﹤0.01% 1252
2019
Q2
$1.23M Sell
57,560
-118,633
-67% -$2.49M ﹤0.01% 1221
2019
Q1
$4.19M Buy
176,193
+113,733
+182% +$2.59M 0.01% 940
2018
Q4
$1.23M Buy
62,460
+40,291
+182% +$718K ﹤0.01% 1122
2018
Q3
$393K Sell
22,169
-49,031
-69% -$956K ﹤0.01% 1393
2018
Q2
$1.53M Buy
71,200
+56,300
+378% +$1.16M ﹤0.01% 1173
2018
Q1
$330K Buy
+14,900
New +$412K ﹤0.01% 1323

Other funds holding EXEL

Amundi Asset Management US's EXEL Position: Q1 2021 in Review

Amundi Asset Management US sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 30,700 shares — an estimated $616K sold.

Amundi Asset Management US first reported a position in EXEL in Q1 2018 and held it in 12 quarters. The position peaked at $4.19M in Q1 2019. 348 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • Amundi Asset Management US reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 30,700 Exelixis shares in Q1 2021, an estimated $616K.
  • Amundi Asset Management US first reported a position in Exelixis in Q1 2018 and held it in 12 quarters.
  • Amundi Asset Management US's Exelixis position peaked at $4.19M in Q1 2019.
  • 348 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.